Press release
Left Appendage Occlusion Device Market Top Companies Study - Atricure, Biosense Webster, Boston Scientific, Abbott Laboratories, Aegis Medical.
Left Appendage Occlusion Device Market
According to the latest research by InsightAce Analytic, the global Left Appendage Occlusion Device market is valued at US$ 960.0 Million in 2022, and it is expected to reach US$ 5381.3 Million by the year 2031, with a CAGR of 21.2% during a forecast period of 2023-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1095
The left atrial appendage occlusion (LAAO) device is employed in procedures such as thoracoscopic left atrial appendage closure and percutaneous transluminal occlusion, serving as an interventional solution to manage atrial fibrillation. During atrial fibrillation, abnormal electrical impulses can lead to the formation of blood clots in the atria and left atrial appendage (LAA), increasing the risk of stroke. LAAO devices are designed to mitigate this risk by preventing clot formation and embolization, thereby reducing the incidence of stroke in patients with atrial fibrillation.
The global market for left atrial appendage occlusion devices is expected to experience robust growth over the forecast period, driven by the increasing prevalence of atrial fibrillation and rising demand for effective stroke prevention solutions. Market expansion is further supported by growing patient and clinician awareness, the introduction of advanced products across international markets, and compelling clinical evidence demonstrating the superior efficacy of LAAO devices compared to conventional anticoagulant therapies such as warfarin and dabigatran. However, the market faces challenges including the need for highly skilled surgical professionals and complex implantation procedures. Additionally, stringent regulatory approval processes may hinder the pace of new product introductions.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
North America is projected to lead the LAAO device market during the forecast period. The region benefits from a well-established medical technology infrastructure, robust contract development and manufacturing organizations (CDMOs), and strong governmental support for healthcare innovation. The increasing incidence of atrial fibrillation and the clinical advantages offered by LAAO devices are key factors driving regional growth.
The Asia Pacific market is also expected to register significant expansion due to rapid technological advancements and the growing elderly population, which is more susceptible to cardiovascular conditions such as atrial fibrillation. The demand for LAAO devices in the region is further bolstered by a surge in government initiatives aimed at enhancing public awareness of cardiovascular diseases, creating favorable conditions for market development.
Major market players operating in the Left Appendage Occlusion Device market include Atricure, Boston Scientific, Biosense Webster, Abbott Laboratories, Aegis Medical, Cardia, Lifetech Scientific, and Sentreheart.
Recent collaborations and agreements in the market:
• In August 2021, the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder manufactured by Abbott Laboratories was given FDA approval in the United States. The purpose of these devices is to treat atrial fibrillation. This approval will help the business increase product sales and take a significant market share in the United States.
• In July 2020, the FDA in the United States approved Boston Scientific Corporation's WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device. This approval helped the business improve the left atrial appendage closure devices it offered, giving it a competitive edge in the market.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1095
Market Segments
Global Left Appendage Occlusion Device Market, by Brand, 2022-2030 (Value US$ Mn)
• Sierra
• AtriClip
• WaveCrest
• Amplatzer Amulet
• WATCHMAN
• Ultrasept
• LAmbre
• LARIAT
Global Left Appendage Occlusion Device Market, by Distribution Channel, 2022-2030 (Value US$ Mn)
• Hospitals
• Ambulatory Surgical Centers
• Heart Clinics
Global Left Appendage Occlusion Device Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Left Appendage Occlusion Device Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Left Appendage Occlusion Device Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Left Appendage Occlusion Device Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Left Appendage Occlusion Device Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Left Appendage Occlusion Device Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Left Appendage Occlusion Device market
To receive an industry overview and future trends of the Left Appendage Occlusion Device market
To analyze the Left Appendage Occlusion Device market drivers and challenges
To get information on the Left Appendage Occlusion Device market value (US$Mn) forecast to 2030
Significant investments, mergers & acquisitions in the Left Appendage Occlusion Device market industry
Read Overview Report- https://www.insightaceanalytic.com/report/global-left-appendage-occlusion-device-market-/1095
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Left Appendage Occlusion Device Market Top Companies Study - Atricure, Biosense Webster, Boston Scientific, Abbott Laboratories, Aegis Medical. here
News-ID: 3985091 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Antimicrobial Peptides Market to Experience Significant Growth Due to Rising Hea …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Antimicrobial Peptides Market - (By Product (Plant Antimicrobial Peptides, Bacterial Antimicrobial Peptides, Animal Antimicrobial Peptides, Insect Antimicrobial Peptides), By Ailments (Pneumonia, Hepatitis, Bacterial infections, HIV), By Route of Administration (Topical, Subcutaneous, Intravenous), By End User (Pharma and Healthcare, Agriculture Industry, Biological Engineering, Others), By Distribution Channel (Hospital, Research Institutes, Specialty Clinic, Pharmacies)), Trends, Industry Competition…
Antimicrobial Irrigation System Market Growth Driven by Advancements in Wound Cl …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Antimicrobial Irrigation System Market - (By Type (Wound Cleanser, Debridement Device), By Application (Traumatology, Surgery, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Antimicrobial Irrigation System Market is predicted to grow with a CAGR of 4.21% during the forecast period of 2024-2031.
Get Free Access…
Antibody Hit Generation and Screening Market Surge Driven by Advancements in Pha …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Antibody Hit Generation and Screening Market Size, Share & Trends Analysis Report By Application (Cancer, Autoimmune diseases, Infectious diseases), Technologies (Hit Generation, Phage display, Yeast display, Ribosome display, B-cell hybridoma technology, Computational tools, Screening), Antibody Type (Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody)- Market Outlook And Industry Analysis 2031"
The Global Antibody Hit Generation and…
Antibody Discovery Market Expected to Achieve 9.10% CAGR Driven by Rising Health …
"Antibody Discovery Market" in terms of revenue was estimated to be worth $7.35 billion in 2023 and is poised to reach $14.52 billion by 2031, growing at a CAGR of 9.10% from 2024 to 2031 according to a new report by InsightAce Analytic.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2287
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global antibody discovery market are:
• Technological advancement
• Increasing…
More Releases for Left
CHERRY Launches the MW 4500 LEFT for Left-Handed Users
KENOSHA, WIS., March 16, 2021 – Cherry Americas, part of the global leader in computer input devices, today announced the release of its new wireless mouse, the MW 4500 LEFT. This ergonomic mouse is designed with functional features for left-handed users and serves as an optimal tool for providing wrist relief in the office and home office.
Best Ergonomics Now Also for Left-Handers
With the MW 4500 LEFT, CHERRY brings…
Left Ventricular Dysfunction - Pipeline Review, H1 2018
Left Ventricular Dysfunction
Overview
Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and Left Ventricular Dysfunction.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811435-left-ventricular-dysfunction-pipeline-review-h1-2018
Top Companies mentioned
Bayer AG
Innopharmax Inc
Mesoblast Ltd
Novartis AG
Quantum Genomics SA
TiGenix NV
Left Ventricular Dysfunction Industry Major Outlook
Pharmaceutical and Healthcare latest pipeline guide Left Ventricular Dysfunction -…
Left Ventricular Dysfunction - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2017, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape.
Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and coronary artery disease.
Report Highlights
Publisher's Pharmaceutical and Healthcare…
Left Ventricular Dysfunction - Pipeline Review, H2 2016
Summary
Global Markets Directs, Left Ventricular Dysfunction - Pipeline Review, H2 2016, provides an overview of the Left Ventricular Dysfunction pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Left Ventricular Dysfunction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development…
Right Brain-Left Brain Connections in Autistic Kids
August 23, 2013: Behavioral scientists know that an ability to process "non-verbal" signals lays the foundation for developing both language and social skills. Dr. Yola Barbosa , a director at a Brain Balance Achievement Center in New Jersey notes, "The ability to process the non-verbal communication lays the foundation of social skills and language.
Kids with autism and even ADHD have a kind of social injury. They may…
Lots of Life Left in 2 & 3G
ELECTRONICS.CA PUBLICATIONS, the electronics industry market research and knowledge network, announces the availability of a new report entitled "Global 3G Market Review".
These days mobile broadband talk is all about LTE, WiMAX and 4G. These topics dominate discussions at trade shows and coverage in trade publications. It is as if 3G is on its death knell and 2G but a distant memory. When looking at the facts however the reality of…
